These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33853745)

  • 61. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Computed tomographic assessment of early changes of the mandible in bisphosphonate-treated patients.
    Taniguchi T; Ariji Y; Nozawa M; Naitoh M; Kuroiwa Y; Kurita K; Ariji E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):362-72. PubMed ID: 27544397
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imaging findings and treatment outcomes of a rare subtype of medication-related osteonecrosis of the jaw.
    Otsuru M; Soutome S; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Umeda M
    J Bone Miner Metab; 2022 Jan; 40(1):150-156. PubMed ID: 34510261
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
    Tezuka Y; Ogura I
    Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
    Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
    J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Progress on medication-related osteonecrosis of the jaw].
    Wang QZ; Liu JY; Pan J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):568-572. PubMed ID: 30465354
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Actinomyces and MRONJ: A retrospective study and a literature review.
    Cerrato A; Zanette G; Boccuto M; Angelini A; Valente M; Bacci C
    J Stomatol Oral Maxillofac Surg; 2021 Nov; 122(5):499-504. PubMed ID: 32827811
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
    Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
    J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medication-Related Osteonecrosis of the Jaws: Two Center Retrospective Cohort Studies.
    Petrovic M; Jelovac DB; Antic S; Antunovic M; Lukic N; Sabani M; Mudrak J; Jezdic Z; Pucar A; Stefanovic A; Kuzmanovic C; Nikolic D; Konstantinovic V
    Biomed Res Int; 2019; 2019():8345309. PubMed ID: 31011580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spontaneous bilateral osteonecrosis of the mandible in a bisphosphonate-naive patient.
    Sklavos AW; Delpachitra SN; Thomas AM; Nastri A
    Br J Oral Maxillofac Surg; 2019 Apr; 57(3):271-274. PubMed ID: 30773304
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparative study of the clinical characteristics of patients with medication-related osteonecrosis of the jaw and osteoporosis or malignancy.
    Feng Z; An J; He Y; Zhang Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):543-547. PubMed ID: 35668004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
    Lee CY; Suzuki JB
    Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.
    Morishita K; Soutome S; Otsuru M; Hayashida S; Murata M; Sasaki M; Takagi Y; Sumi M; Umeda M
    Sci Rep; 2022 Jul; 12(1):11545. PubMed ID: 35799050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.
    Sim IeW; Sanders KM; Borromeo GL; Seymour JF; Ebeling PR
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3887-93. PubMed ID: 26241323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
    Muttanahally KS; Tadinada A
    Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.